S. Ray et al. / Tetrahedron Letters 54 (2013) 2164–2170
2169
90
80
70
60
50
40
References and notes
% conversion
1. Orchard, A.; Schamerhorn, G. A.; Calitree, B. D.; Sawada, G. A.; Loo, T. W.; Claire
Bartlett, M.; Clarke, D. M.; Detty, M. R. Bioorg. Med. Chem. 2012, 20, 4290; (b)
Gottesman, M. M.; Fojo, T.; Bates, S. E. Nat. Rev. Cancer 2002, 2, 48; (c) Szakacs,
G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C.; Gottesman, M. M. Nat. Rev.
Drug Disc. 2006, 5, 219; (d) Gannon, M. K.; Holt, J. J.; Bennett, S. M.; Wetzel, B.
R.; Loo, T. W.; Bartlett, M. C.; Clarke, D. M.; Sawada, G. A.; Higgins, J. W.;
Tombline, G.; Raub, T. J.; Detty, M. R. J. Med. Chem. 2009, 52, 3328; (e) Wang, F.;
Langley, R.; Gulten, G.; Dover, L. G.; Besra, G. S.; Jacobs, W. R., Jr.; Sacchettini, J.
C. J. Exp. Med. 2007, 204, 73; (f) Fajardo, T. T.; Guinto, R. S.; Cellona, R. V.; Abalos,
R. M.; Dela Cruz, E. C.; Gelber, R. H. Am. J. Trop. Med. Hyg. 2006, 74, 457; (g)
Yajko, D. M.; Nassos, P. S.; Hadley, W. K. Antimicrob. Agents Chemother. 1987, 31,
117; (h) Crofton, J.; Chaulet, P.; Maher, D.; Grosset, J.; Harris, W.; Norman, H.;
Iseman, M.; Watt, B. Guidelines for the Management of Multidrug-Resistant
Tuberculosis; World Health Organization: Geneva, Switzerland, 1997; (i)
Nishida, C. R.; Ortiz de Montellano, P. R. Chem. Biol. Interact. 2011, 192, 21; (j)
Zbruyev, O. I.; Stiasni, N.; Kappe, C. O. J. Comb. Chem. 2003, 5, 145; (k) Kaleta, Z.;
Makowski, B. T.; Soos, T.; Dembinski, R. Org. Lett. 2006, 8, 1625; (l) Abai, M.;
Holbrey, J. D.; Rogersz, R. D.; Srinivasan, G. New J. Chem. 2010, 34, 1981; (m)
Bowmaker, G. A.; Chaichit, N.; Hanna, J. V.; Pakawatchai, C.; Skeltone, B. W.;
White, A. H. Dalton Trans. 2009, 8308; (n) Pathare, S. P.; Chaudhari, P. S.;
Akamanchi, K. G. Appl. Catal., A: Gen. 2012, 425–426, 125; (o) Nguyen, T. B.;
Ermolenko, L.; Al-Mourabit, A. Org. Lett. 2012, 14, 4274; (p) Wipf, P.;
Venkatraman, S. J. Org. Chem. 1996, 61, 8004; (q) Attanasi, O. A.; Berretta, S.;
Crescentini, L. D.; Favi, G.; Filippone, P.; Giorgi, G.; Lillini, S.; Mantellini, F.
Tetrahedron Lett. 2007, 48, 2449; (r) Attanasi, O. A.; Crescentini, L. D.; Favi, G.;
Filippone, P.; Giorgi, G.; Mantellini, F.; Perrulli, F. R.; Spinelli, D. Tetrahedron
Lett. 2008, 49, 3837.
0
1
2
3
4
5
6
7
8
9
10 11
Cycles
Figure 8. Recycling of MCM-41 catalyst for the reaction forming 4a.
The reactions were carried out using different amounts of the
catalyst and the optimum amount (40 mg) has been determined
(optimization table is given in Supplementary data) Determination
of this optimum amount to achieve maximum yield was very
essential to establish the efficacy and broaden the applicability of
the proposed process. For this purpose the reaction forming 4j
was chosen as a test reaction.
2. Padwa, A.; Beall, L. S.; Heidelbaugh, T. M.; Bing, L.; Sheehan, S. M. J. Org. Chem.
2000, 65, 2684.
3. McManus, S. P.; Lee, K. Y.; Pittman, C. U. J. Org. Chem. 1974, 39, 3041.
4. (a) Jagodzinski, T. S. Chem. Rev. 2003, 103, 197; (b) Prokopcova, H.; Kappe, C. O.
J. Org. Chem. 2007, 72, 4440.
5. Pathak, U.; Pandey, L. K.; Tank, R. J. Org. Chem. 2008, 73, 2890.
6. (a) Jesberger, M.; Davis, T. P.; Barner, L. Synthesis 2003, 1929; (b) Cava, M. P.;
Levinson, M. I. Tetrahedron 1985, 41, 5061.
7. (a) Hurd, R. N.; DeLaMater, G. Chem. Rev. 1961, 61, 45; (b) Brillon, D. Sulfur Rep.
1992, 12, 297.
8. (a) Asquith, R. S.; Hammick, D. Ll; Williams, P. L. J. Chem. Soc. 1948, 1181; (b)
Fournier, C.; Paquer, D.; Vazeux, M. Bull. Soc. Chim. Fr. 1975, 2753.
9. Zong, Z.-M.; Peng, Y.-L.; Liu, Z.-G.; Zhou, S.-L.; Wu, L.; Wang, X.-H.; Wei, X.-Y.;
Lee, C. W. Korean J. Chem. Eng. 2003, 20, 235.
10. (a) Oae, S.; Nakanishi, A.; Tsujimoto, N. Chem. Ind. 1972, 575; (b) Pedersen, B. S.;
Lawesson, S. O. Bull. Soc. Chim. Belg. 1977, 86, 693.
In the presence of MCM-41 (preheated at 100 °C for 4 h) the
reaction between benzamide, rhodanine and morpholine occurred
with 89% yield of 4j. The same reaction in the presence of MCM-41
after having it exposed to ambient atmosphere for 10 days pro-
duced a similar observation. Obviously, there was no deteriorating
effect of heat, aerial oxygen or moisture towards activity of the cat-
alyst which also provided evidence that the catalyst had the poten-
tial of efficient recycling. The recycled catalyst could be used at
least ten times with almost same efficiency as that of the first
run without any further treatment (Fig. 8). Detailed characteriza-
tion of the catalyst after 5th run showed that it was unaffected un-
der the condition of the reaction. The XRD pattern of the recovered
catalyst showed sharp peaks at 2.6° and 4.4° corresponding to 3D-
hexagonal mesophase indicating that the mesoporous structure of
MCM-41 still remained intact after recycling.
It is the first report of the use of rhodanine as the potential thi-
onating agent for amide and MCM-41 is being used for thionation
purpose also for the first time. Moreover, the entire process was
highly atom-efficient. So the present protocol minimizes the dis-
persal of the harmful chemicals in the environment and maximizes
the use of renewable resources. In this light, this highly efficient
catalytic process41 can also be considered as a green technology.
The unprecedented catalytic performance demonstrated by
MCM-41 holds a significant promise for the achievement of novel
catalyst systems. The new catalytic procedures for the thionation
of amide fulfil the triple bottom-line philosophy of green chemistry
and are important addition to the toolbox of medicinal chemists.
The spectral and analytical data42 of one representative compound
(4a) is provided in the main manuscript.
11. Ishii, Y.; Hirabayashi, T.; Imaeda, H.; Ito, Jpn, K. Patent 4,0441, 1974; Chem.
Abstr. 1975, 82, 156074f.
12. Bodine, J. J.; Kaloustian, M. K. Synth. Commun. 1982, 12, 787.
13. Smith, D. C.; Lee, S. W.; Fuchs, P. L. J. Org. Chem. 1994, 59, 348.
14. (a) Pedersen, B. S.; Scheibye, S.; Nilsson, N. H.; Lawesson, S. O. Bull. Soc. Chim.
Belg. 1978, 87, 223; (b) Yang, C. O.; Rotstein, D. M.; Labadie, S. S.; Walker, K. A.
M. Synlett 1995, 655.
15. Charette, A. B.; Grenon, M. J. Org. Chem. 2003, 68, 5792.
16. (a) Dean, F. M.; Goodchild, J.; Hill, A. W. J. Chem. Soc. 1969, 2192; (b) Dean, F.
M.; Goodchild, J.; Hill, A. W.; Moore, S.; Zahman, A. J. Chem. Soc., Perkin Trans. 1
1975, 1335.
17. Degl’Innocenti, A.; Capperucci, A.; Castagnoli, G.; Malesci, I. Synlett 2005, 1965.
18. Leadbeater, N. E.; Marco, M. Chem. Rev. 2002, 102, 3217.
19. Rafiee, E.; Eavani, S. Green Chem. 2011, 13, 2116.
20. Lee, C. L.; Sim, M. M. Tetrahedron Lett. 2000, 41, 5729.
21. (a) Troutman, H. D.; Long, L. M. J. Am. Chem. Soc. 1948, 70, 3436; (b) Mishra, S.;
Srivastava, S. K.; Srivastava, S. D. Indian J. Chem., Sect. B 1997, 36, 826.
22. Foye, W. O.; Tovivich, P. J. Pharm. Sci. 1977, 66, 1607.
23. Sudo, K.; Matsumoto, Y.; Matsushima, M.; Fujiwara, M.; Konno, K.;
Shimotohno, K.; Shigeta, S.; Yokota, T. Biochem. Biophy. Res. Commun. 1997,
238, 643.
24. Ohishi, Y.; Mukai, T.; Nagahara, M.; Yajima, M.; Kajikawa, N.; Miyahara, K.;
Takano, T. Chem. Pharm. Bull. 1990, 38, 1911.
25. (a) Pulici, M.; Quartieri, F. Tetrahedron Lett. 2005, 46, 2387; (b) Kandeel, K. A.;
Youssef, A. M.; El-Bestawy, H. M.; Omar, M. T. J. Chem. Res., Synop. 2003, 11,
682.
Acknowledgments
26. Bourahla, K.; Derdour, A.; Rahmouni, M.; Carreaux, F.; Bazureau, J. P.
Tetrahedron Lett. 2007, 48, 5785.
27. Anderluh, M.; Jukic, M.; Petric, R. Tetrahedron 2009, 65, 344.
28. Mukhopadhyay, C.; Ray, S. Tetrahedron Lett. 2011, 52, 6431.
29. Mukhopadhyay, C.; Ray, S. Tetrahedron 2011, 67, 7936.
We acknowledge UGC for financial support (F. No. 37-398/2009
(S.R.) dated 11-01-2010), CSIR for fellowship (S.R.) and NMR Re-
search Centre, IISc, Bangalore-560012 for the solid state Si-29
MAS NMR spectrum.
30. Mukhopadhyay, C.; Ray, S. Catal. Commun. 2011, 12, 1496.
31. Das, P.; Butcher, R. J.; Mukhopadhyay, C. Green Chem. 2012, 14, 1376.
32. Mukhopadhyay, C.; Rana, S. Catal. Commun. 2009, 11, 285.
33. Abhinit, M.; Ghodke, M.; Pratima, N. A. Int. J. Pharm. Pharm. Sci. 2009, 1, 47.
34. (a) Mulwad, V. V.; Mir, A. A.; Parmar, H. T. Indian J. Chem. 2009, 48B, 137; (b)
Chavan, A. A.; Pai, N. R. Arkivoc 2007, xvi, 148; (c) Vigorita, M. G.; Ottana, R.;
Monforte, F.; Maccari, R.; Trovato, A.; Monforte, M. T.; Taviano, M. F. Bioorg.
Med. Chem. Lett. 2001, 11, 2791.
Supplementary data
Supplementary data associated with this article can be found, in